Carboline compounds usable in the treatment of neurodegenerative diseases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9714245
APP PUB NO 20160152610A1
SERIAL NO

14900248

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a compound according to Formula (A) or a pharmaceutically acceptable salt, solvate, clathrate, hydrate or polymorph thereof, and its use.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)101 RUE DE TOLBIAC PARIS 75013
UNIVERSITE DE LILLE 2 DROIT ET SANTE42 RUE PAUL DUEZ LILLE 59800
ALZPROTECT59120 LOOS

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Burlet, Stephane Croix, FR 2 0
Carato, Pascal Ronchin, FR 10 29
Estrella, Cecilia Lomme, FR 1 0
Melnyk, Patricia Annouellin, FR 13 7
Nguyen, Emilie Le Mans, FR 11 79
Sergeant, Nicolas Ronchin, FR 18 141
Verwaerde, Philippe Santes, FR 15 36

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 25, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 25, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00